DSE:BXPHARMA Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	4,228	1,700	854.11	1,136	1,169	675.47
Short-Term Investments	1,557	1,098	369.37	166.25	108.07	112.83
Cash & Short-Term Investments	5,784	2,798	1,223	1,302	1,277	788.3
Cash Growth	76.19%	128.68%	-6.03%	1.97%	61.96%	11.69%
Accounts Receivable	3,768	3,114	3,462	3,370	2,963	2,726
Other Receivables	-	514.97	304.98	215.62	217.35	174.05
Receivables	3,768	3,629	3,767	3,586	3,180	2,900
Inventory	15,558	14,762	13,307	13,473	11,573	8,265
Prepaid Expenses	-	178.83	136.62	60.96	53.23	36.03
Other Current Assets	2,956	2,418	2,383	2,455	2,335	1,781
Total Current Assets	28,067	23,786	20,818	20,876	18,419	13,771
Property, Plant & Equipment	45,246	44,027	43,049	42,808	42,212	36,531
Long-Term Investments	20.97	20.97	20.97	20.97	23.36	16.59
Goodwill	674.57	674.57	674.57	674.57	674.57	546.69
Other Intangible Assets	4,689	4,694	4,721	4,721	4,730	1,381
Long-Term Deferred Tax Assets	33.78	44.08	60.89	56.51	88.64	-
Total Assets	78,731	73,247	69,344	69,157	66,148	52,246
Accounts Payable	2,124	1,564	1,402	1,618	1,373	769.2
Accrued Expenses	1,394	2,132	2,832	2,581	2,042	1,420
Short-Term Debt	973.57	2,025	2,997	6,621	6,851	5,023
Current Portion of Long-Term Debt	801.16	1,318	1,132	1,293	1,905	1,287
Current Portion of Leases	90.39	118.38	139.3	146.52	160.58	113.98
Current Income Taxes Payable	1,282	528.63	429.27	454.09	99.45	222.51
Current Unearned Revenue	-	58.04	80.24	149.41	110.41	298.4
Other Current Liabilities	137.93	648.55	551.38	401.5	193.85	214.81
Total Current Liabilities	6,803	8,393	9,562	13,265	12,736	9,350
Long-Term Debt	1,090	1,202	1,433	2,158	2,997	972.7
Long-Term Leases	208.38	301.52	324.72	393.12	456.76	234.02
Pension & Post-Retirement Benefits	3,952	2,175	2,104	1,876	1,624	1,322
Long-Term Deferred Tax Liabilities	2,582	2,576	2,575	2,550	2,537	1,990
Other Long-Term Liabilities	-	1,516	1,443	1,295	1,161	1,013
Total Liabilities	14,635	16,163	17,441	21,537	21,512	14,881
Common Stock	4,461	4,461	4,461	4,461	4,461	4,461
Additional Paid-In Capital	6,959	6,959	6,959	6,959	6,959	6,959
Retained Earnings	47,184	40,240	35,079	30,806	27,748	24,180
Comprehensive Income & Other	1,445	1,447	1,450	1,454	1,432	1,431
Total Common Equity	60,048	53,107	47,950	43,681	40,600	37,031
Minority Interest	4,048	3,977	3,953	3,939	4,036	334.31
Shareholders' Equity	64,096	57,085	51,903	47,620	44,636	37,365
Total Liabilities & Equity	78,731	73,247	69,344	69,157	66,148	52,246
Total Debt	3,163	4,966	6,025	10,612	12,371	7,631
Net Cash (Debt)	2,621	-2,168	-4,802	-9,310	-11,094	-6,843
Net Cash Per Share	5.87	-4.86	-10.76	-20.87	-24.87	-15.34
Filing Date Shares Outstanding	446.11	446.11	446.11	446.11	446.11	446.11
Total Common Shares Outstanding	446.11	446.11	446.11	446.11	446.11	446.11
Working Capital	21,263	15,393	11,256	7,611	5,683	4,421
Book Value Per Share	134.60	119.04	107.48	97.91	91.01	83.01
Tangible Book Value	54,685	47,738	42,555	38,285	35,196	35,103
Tangible Book Value Per Share	122.58	107.01	95.39	85.82	78.90	78.69
Land	7,892	7,892	7,892	7,892	-	4,068
Buildings	17,058	16,988	17,005	16,704	-	8,129
Machinery	34,839	34,419	33,219	31,733	-	18,663
Construction In Progress	5,307	3,293	1,938	1,847	-	16,507